Last updated: 2026-09-16 09:46:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
SIGA Technologies Inc. (SIGA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.99, with a market capitalisation of $226.33M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.83 to $9.45. This page covers its latest market performance, valuation, price trends and company information.
$226.33M | |
$3.14 | |
$26.99 | |
$0.69 | |
$3.15 | |
422.24K | |
729.86K | |
-- | |
$9.45 | |
$2.83 | |
20.34% | |
-- |
SIGA Technologies Inc. (SIGA) is trading at $3.13 in pre-market trading as of 2026-09-15 23:31:00, down 0.63% ($0.02) from the previous close of $3.15
Pre-market trading shows how investors are pricing SIGA before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, SIGA Technologies Inc. (SIGA) moved from $3.29 to $2.99, representing a decline of 9.27% ($0.31).
The stock traded between $2.94 and $3.32 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 610.73 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.3%
SIGA is currently trading at $2.99, placing it 2.3% of the way from its 52-week low of $2.83 to its 52-week high of $9.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 49 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of SIGA Technologies Inc. (SIGA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.